COVID-19 trials registries data warehouse

https://anzctr.org.au/ACTRN12621001108808.aspx

Abdus Shakoor

shakoorma@bsmmu.edu.bd

2021-08-20

Not recruiting

RCT

Randomized

Parallel

Open label

single-center

Treatment

• Nasopharyngeal swab samples (tested by RT-PCR) positive for the novel coronavirus. • Subjects Aged 15 years or more of all genders. • Oxygen saturation as measured by pulse oximetry (SpO2) greater than 90 % in room air. • Patients having symptoms mild to moderate in nature • A resting respiratory rate 30/m or less than 30/m. • Able to understand the content of questionnaires and who will provide informed consent.

• Subjects aged more than 70 years of all genders. • Subjects having severe form of COVID-19 • Subjects having severe COPD, bronchial asthma and severe ischemic heart disease. • Pregnant woman will be excluded from the study.

2

BANGLADESH MEDICAL RESEARCH COUNCIL

15

70

Bangladesh

Mild/moderate disease at enrollment

2: Mild/moderate disease at enrollment

155

Breathing difficulty will be assessed by using Modified Medical Research Council (MMRC) scale.[ At week one with week 2; 3 and 4 (post-enrolment)];Modified Borg Scale (MBS) to determine the breathing difficulty after exercise[Weekly for four weeks post-enrolment]

Not reported

[{"arm_notes": "", "treatment_id": 1043, "treatment_name": "Pulmonary rehabilitation", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]